Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pseudolymphoma
ADR ID BADD_A03606
ADR Hierarchy
01      Blood and lymphatic system disorders
01.09      Spleen, lymphatic and reticuloendothelial system disorders
01.09.01      Lymphatic system disorders NEC
01.09.01.016      Pseudolymphoma
Description A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (From Dorland, 28th ed & Stedman, 26th ed) [MeSH]
MedDRA Code 10037127
MeSH ID D019310
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Benign lymphoma | Hodgkin's-like | Hodgkins-like | Lymphoma benign | Lymphoma like reaction | Lymphoma-like disorder | Lymphoma-like reaction | Lymphomoid | Lymphosarcomoid | Pseudo lymphoma | Pseudolymphoma | Reaction lymphoma-like | Lymphocytoma cutis | Pseudolymphomas | Lymphoid Hyperplasia, Reactive | Lymphocytoma | Lymphocytomas | Hyperplasia, Reactive Lymphoid | Hyperplasias, Reactive Lymphoid | Lymphoid Hyperplasias, Reactive | Reactive Lymphoid Hyperplasia | Reactive Lymphoid Hyperplasias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01909Ramipril0.000093%
BADD_D02002Selegiline--
BADD_D02026Simvastatin0.000034%
BADD_D02325Valdecoxib--
BADD_D02329Valproic acid0.000100%
BADD_D02344Vemurafenib0.000168%
BADD_D02464Fingolimod0.000241%
The 2th Page    First    Pre   2    Total 2 Pages